Citigroup raises H.B. Fuller price target to $75

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Citigroup analyst Patrick Cunningham maintained a Buy rating on H.B. Fuller and raised the price target to $75 from $70, reflecting a positive outlook on the company's performance.

powered bylight_fuzz_icon
44393188

*this image is generated using AI for illustrative purposes only.

Citigroup analyst Patrick Cunningham has maintained a Buy rating on H.B. Fuller while raising the company's price target. The new target stands at $75, an increase from the previous $70.

The adjustment reflects the analyst's outlook on the company's performance. H.B. Fuller trades on the NYSE under the ticker symbol FUL.

Metric Value
Rating Buy
Previous Price Target $70
New Price Target $75

What specific factors are driving the analyst's increased optimism for H.B. Fuller's future performance?

How might this price target adjustment influence investor sentiment toward H.B. Fuller in the short term?

What are the potential risks or challenges H.B. Fuller could face that could impact its ability to meet the new price target?

like15
dislike

JP Morgan upgrades H.B. Fuller to Overweight, raises target to $67

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

JP Morgan analyst Jeffrey Zekausas upgraded H.B. Fuller from Neutral to Overweight and raised the price target to $67 from $58.

powered bylight_fuzz_icon
44028727

*this image is generated using AI for illustrative purposes only.

JP Morgan analyst Jeffrey Zekauskas upgraded H.B. Fuller to Overweight from Neutral, signaling increased confidence in the company's stock performance. The firm raised its price target for the company to $67 from the previous $58.

Rating and Target Changes

The upgrade reflects a revised outlook on H.B. Fuller's potential. The following table summarizes the changes:

Metric Previous New
Rating Neutral Overweight
Price Target $58 $67

The new price target represents a significant adjustment from the prior estimate.

What specific factors drove JP Morgan's increased confidence in H.B. Fuller's stock performance?

How might H.B. Fuller's competitors react to this upgrade and target price increase?

What are the potential risks that could prevent H.B. Fuller from reaching the new $67 price target?

like18
dislike

More News on H.B. Fuller Co

Must Read Next

Corporate Actions

Aurobindo Pharma schedules analyst and investor meet on September 22 10 mins ago
Global Health schedules analyst and investor meetings on September 17 and 18 10 mins ago
KPIT Technologies schedules analyst and investor meetings on Sep 21 and 22 10 mins ago
no imag found